{"doi":"10.1016/j.drugalcdep.2006.07.009","title":"Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users","abstract":null,"journal":"Drug and Alcohol Dependence","year":2007,"id":662452,"datarank":0.8638352660815922,"base_score":5.75890177387728,"endowment":5.75890177387728,"self_citation_contribution":0.8638352660815922,"citation_network_contribution":0.0,"self_endowment_contribution":0.8638352660815922,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":316,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":4,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":333707,"name":"Nadia Fairbairn","orcid":"0000-0002-4195-3284","position":1,"is_corresponding":false},{"id":1729417,"name":"Mark Tyndall","orcid":null,"position":2,"is_corresponding":false},{"id":214641,"name":"David Marsh","orcid":null,"position":3,"is_corresponding":false},{"id":539623,"name":"Kathy Li","orcid":"0000-0001-9971-2822","position":4,"is_corresponding":false},{"id":311292,"name":"Julio Montaner","orcid":"0000-0003-0217-6379","position":5,"is_corresponding":false},{"id":126108,"name":"Evan Wood","orcid":null,"position":6,"is_corresponding":false},{"id":1450043,"name":"Thomas Kerr","orcid":"0000-0003-2218-8641","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users","abstract":"<h4>Background</h4>Non-fatal overdose is a major determinant of morbidity among injection drug users (IDU). We sought to evaluate factors associated with non-fatal overdose among IDU in Vancouver.<h4>Methods</h4>We examined non-fatal overdose among participants in the Vancouver Injection Drug Users Study. Correlates of non-fatal overdose occurring between 1996 and 2004 were identified using generalized estimating equations (GEE).<h4>Results</h4>There were 1587 participants included in this analysis, including 576 (36%) women. At baseline, 750 (47%) reported a history of non-fatal overdose. In total, 985 reports of non-fatal overdose were made during follow-up by 519 (32.7%) participants. In multivariate GEE analyses, factors independently associated with non-fatal overdose included: heroin injection (AOR=2.67), cocaine injection (AOR=2.01), benzodiazepine use (AOR=2.00), requiring help injecting (AOR=1.58), binge drug use (AOR=1.52), homelessness (AOR=1.38), alcohol use (AOR=1.32), street injecting (AOR=1.22), non-injectable opiate use (AOR=1.16), speedball use (AOR=1.15), and recent incarceration (AOR=1.14). Younger age (AOR=0.99) and methadone use (AOR=0.51) were protective.<h4>Conclusions</h4>We found that non-fatal overdose was common among local IDU. Non-fatal overdose was associated with several factors that may be amenable to intervention, including opiate and stimulant use, and the characteristic of requiring help with injecting. These findings indicate the need for the ongoing development of structural interventions to address this common cause of morbidity among IDU.","is_dataset_classified":null,"base_score":5.75890177387728,"endowment":5.75890177387728,"datacite_reuse_total":4,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"16959438","pmcid":null,"openalex_id":"https://openalex.org/W2100628044","authors":[],"funders":[{"funder_name":"NIDA NIH HHS","grant_id":"R01 DA011591-04A1","title":null}],"total_grants":1,"fwci":10.0038,"citation_percentile":0.98673214,"influential_citations":0,"citation_trend":[{"year":2012,"count":11},{"year":2013,"count":20},{"year":2014,"count":13},{"year":2015,"count":23},{"year":2016,"count":18},{"year":2017,"count":24},{"year":2018,"count":27},{"year":2019,"count":21},{"year":2020,"count":19},{"year":2021,"count":14},{"year":2022,"count":13},{"year":2023,"count":14},{"year":2024,"count":12},{"year":2025,"count":5},{"year":2026,"count":5}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0376871606002882?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0376871606002882?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.drugalcdep.2006.07.009","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/16959438","host_type":"repository"}],"fields_of_study":["HIV, Drug Use, Sexual Risk","Opioid Use Disorder Treatment","Substance Abuse Treatment and Outcomes","Adolescent","Child","Cocaine","Cohort Studies","Drug Overdose","Female","Follow-Up Studies","Heroin","Humans","Male","Methadone","Narcotics","Periodicity","Predictive Value of Tests","Prevalence","Prospective Studies","Substance Abuse, Intravenous","Surveys and Questionnaires"],"mesh_terms":["Adolescent","Child","Cocaine","Heroin","Female","Follow-Up Studies","Humans","Male","Methadone","Narcotics","Periodicity","Predictive Value of Tests","Prospective Studies","Surveys and Questionnaires","Cohort Studies","Substance Abuse, Intravenous","Prevalence","Drug Overdose"],"keywords":["Polysubstance dependence","Medicine","Gee","Drug overdose","Heroin","Generalized estimating equation","Methadone","Psychological intervention","Cohort","Drug","Substance abuse","Emergency medicine","Poison control","Psychiatry","Internal medicine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.22607152.v1","title":"Additional file 1 of Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22607152","title":"Additional file 1 of Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.23354271.v1","title":"Additional file 1 of The POP (Permanent Supportive Housing Overdose Prevention) Study: protocol for a hybrid type 3 stepped-wedge cluster randomized controlled trial","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.23354271","title":"Additional file 1 of The POP (Permanent Supportive Housing Overdose Prevention) Study: protocol for a hybrid type 3 stepped-wedge cluster randomized controlled trial","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-12T15:03:33.225950Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}